BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22543914)

  • 61. Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer.
    See HT; Thomas DA; Bueso-Ramos C; Kavanagh J
    Int J Gynecol Cancer; 2006; 16 Suppl 1():236-40. PubMed ID: 16515597
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
    Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
    Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
    [No Abstract]   [Full Text] [Related]  

  • 63. [Treatment of recurrent ovarian cancer].
    Kudo R; Sagae S
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1991-7. PubMed ID: 1358032
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Brain metastasis of ovarian cancer after negative second-look laparotomy.
    Akhan SE; Işikoglu M; Salihoglu Y; Bengisu E; Berkman S
    Eur J Gynaecol Oncol; 2002; 23(4):330-2. PubMed ID: 12214736
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnosis and management of ovarian cancer.
    DiSaia PJ
    Hosp Pract (Off Ed); 1987 Apr; 22(4):235-50. PubMed ID: 3104363
    [No Abstract]   [Full Text] [Related]  

  • 66. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ray-Coquard I; Morice P; Lorusso D; Prat J; Oaknin A; Pautier P; Colombo N;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv1-iv18. PubMed ID: 29697741
    [No Abstract]   [Full Text] [Related]  

  • 67. Ovarian cancer, version 3.2012.
    Morgan RJ; Alvarez RD; Armstrong DK; Burger RA; Castells M; Chen LM; Copeland L; Crispens MA; Gershenson D; Gray H; Hakam A; Havrilesky LJ; Johnston C; Lele S; Martin L; Matulonis UA; O'Malley DM; Penson RT; Remmenga SW; Sabbatini P; Santoso JT; Schilder RJ; Schink J; Teng N; Werner TL; Hughes M; Dwyer MA;
    J Natl Compr Canc Netw; 2012 Nov; 10(11):1339-49. PubMed ID: 23138163
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recurrent ovarian cancer: when and how to treat.
    Hall M; Rustin G
    Curr Oncol Rep; 2011 Dec; 13(6):459-71. PubMed ID: 22045509
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ovarian cancer in BRCA-positive women: vigilance is mandatory despite screening programs.
    Sloots K; Ausems MG; de Haan HH
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):196-8. PubMed ID: 11858898
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unsettled questions regarding ovarian cancer.
    Tropé C; Makar A
    Acta Obstet Gynecol Scand Suppl; 1992; 155():7-18. PubMed ID: 1502893
    [No Abstract]   [Full Text] [Related]  

  • 71. Importance of ultrasonography in the follow-up of patients treated for ovarian carcinoma.
    Juhász B; Hernádi Z; Tóth Z; Lampé L
    Int J Gynaecol Obstet; 1984 Oct; 22(5):349-55. PubMed ID: 6151918
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The treatment of microscopic residual ovarian cancer with intraperitoneal interferon: a clinical and flow cytometric study.
    Whelan JS; van Dam PA; Shepherd JH; Slevin ML
    Br J Obstet Gynaecol; 1992 Jul; 99(7):615-7. PubMed ID: 1525107
    [No Abstract]   [Full Text] [Related]  

  • 73. Ovarian carcinoma. Advances in diagnosis, staging, and treatment.
    Averette HE; Donato DM
    Cancer; 1990 Feb; 65(3 Suppl):703-8. PubMed ID: 2405997
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The management of ovarian cancer: an update.
    Onnis A
    Eur J Gynaecol Oncol; 1997; 18(3):157-60. PubMed ID: 9174825
    [No Abstract]   [Full Text] [Related]  

  • 75. Recent advances in the staging and treatment of ovarian cancer.
    Anderson T; Young RC
    Med Clin North Am; 1977 Sep; 61(5):1001-12. PubMed ID: 330970
    [No Abstract]   [Full Text] [Related]  

  • 76. Reexploration after treatment for ovarian carcinoma.
    Phillips BP; Buchsbaum HJ; Lifshitz S
    Gynecol Oncol; 1979 Dec; 8(3):339-45. PubMed ID: 389753
    [No Abstract]   [Full Text] [Related]  

  • 77. Current issues in ovarian cancer.
    Granai CO
    Hosp Pract (Off Ed); 1994 Feb; 29(2):23-30. PubMed ID: 8300765
    [No Abstract]   [Full Text] [Related]  

  • 78. Are we doing well or oversizing follow-up in ovarian cancer? Searching for tailoring.
    Sierra SM; De Santiago García FJ
    Int J Gynecol Cancer; 2015 Jun; 25(5):760. PubMed ID: 25996531
    [No Abstract]   [Full Text] [Related]  

  • 79. Staging in ovarian cancer.
    Mackintosh J
    Med J Aust; 1988 Jul; 149(2):107-8. PubMed ID: 3393102
    [No Abstract]   [Full Text] [Related]  

  • 80. Ovarian cancer.
    Young RC
    CA Cancer J Clin; 1995; 45(2):69-70. PubMed ID: 7889391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.